Cadila Posts robust quarter with 264% QoQ PAT growth
Cadila Healthcare reported strong results for the quarter ended September 30, 2017, during market hours on Tuesday.
Total sales for this quarter, Q2FY18, came in at Rs. 3,234 crore. This represents a 45.1 per cent sequential increase and 34.55 per cent YoY increase.
Operating profit (EBIT) for the recently concluded quarter amounted to Rs. 857.1 crore and the EBIT margin stood at 26.5 per cent.
In terms of the bottom-line, the company reported a PAT figure of Rs. 503.3 crore which represents a sequential QoQ increase of 264 per cent and a YoY increase of 32.48 per cent.
The company's stock which opened for trading at Rs. 451 per share on the BSE, has risen by 3.28 per cent after the results were declared and at 12:49 hours, trading at around the Rs. 465.55 mark.